ObservSMART Continues Rollout of Patient Safety Technology

AltaPointe Health is the Latest Healthcare System to Utilize Innovative Compliance Solution

ObservSMART, a patient safety compliance solution, announced today that AltaPointe Health in Mobile, Alabama, has recently started using its technology to ensure patient safety while reducing risk, errors, and costs.

An easy-to-use observation tool, ObservSMART is an innovative product of InvisALERT Solutions, developed to improve patient safety and overall quality of care for high-risk patient populations.

AltaPointe Health has deployed the ObservSMART technology at BayPointe Hospital, which treats pediatric psychiatric patients, and at EastPointe Hospital, which cares for adults.

“BayPointe Hospital provides more than 100,000 hospital services to children each year, and safety is our top priority. Incorporating ObservSMART, the next generation of technology, into our daily patient observations helps us ensure patient safety while maintaining the highest quality of care,” said Jarrett Crum, Chief Hospital Officer for AltaPointe Health.

ObservSMART is a proximity-based system that syncs a patented, tamper-resistant wristband with a tablet to validate required patient observations, specifically designed for higher acuity patient populations, or patients in need of frequent monitoring. The staff member needs to be within a certain proximity to the patient to validate their patient check. The ObservSMART App also provides real-time staff reminders to check on their patients. In addition, leadership and other supervisors receive alerts for missed observations and additional safety concerns, allowing them to intervene in real-time, mitigating the potential of risk.

“In today’s health care landscape, patients expect hospitals and health systems to provide high-quality care. Keeping our programs on the cutting edge of technology allows us to meet and hopefully exceed those expectations,” said Steve Dolan, VP of Administrative Services for AltaPointe Health.

Christopher Dunn, Senior Vice President with ObservSMART, looks forward to working in partnership with AltaPointe Health, a leading provider in Alabama, to improve patient safety, staff communications, and accountability to provide the highest quality of care to its patients.

“Our technology aligns well with AltaPointe’s quality of care initiatives and the exceptional standards already in place. ObservSMART will help them in their quest to better assist those suffering from behavioral health challenges” he said.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”